Immuron (IMRN) Current Taxes (2022 - 2023)
Immuron's quarterly Current Taxes came in at $948.25 in Q4 2023, down 91.03% year-on-year from $10567.3 in Q4 2022, and down 99.79% quarter-over-quarter from $457652.7 in Q3 2023.
Immuron has reported Current Taxes for 2 years, with the latest figure at $948.25 in Q4 2023.
- For the quarter ending Q4 2023, Current Taxes fell 91.03% year-over-year to $948.25; the trailing twelve-month figure through Dec 2023 stood at $948.25 (down 91.03% YoY), and the FY2023 full-year result was $6982.0, down 33.93% from the prior year.
- Current Taxes for Q4 2023 stood at $948.25, down from $457652.7 in the prior quarter.
- The five-year high for Current Taxes was $457652.7 in Q3 2023, with the low at $948.25 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 10,460.56 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 19.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Immuron | 1.27 Bn | 1.27 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 948.25 |
| Sep 28, 2023 | 457,652.70 |
| Aug 30, 2023 | 6,981.95 |
| Jun 30, 2023 | 4,666.46 |
| Dec 31, 2022 | 10,567.29 |